Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
1.097 Leser
Artikel bewerten:
(2)

Delisting of Securities of Nymox Pharmaceutical Corporation; Aridis Pharmaceuticals Inc.; Novan, Inc.; ViewRay, Inc.; 9 Meters Biopharma, Inc.; Nabriva Therapeutics plc; UTA Acquisition Corporation; AppHarvest, Inc.; Yellow Corporation; Proterra Inc.; Amy

NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Nymox Pharmaceutical Corporation. Nymox Pharmaceutical Corporation's securities were suspended on July 7, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Aridis Pharmaceuticals Inc. Aridis Pharmaceuticals Inc.'s securities were suspended on July 19, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Novan, Inc. Novan, Inc.'s securities were suspended on July 26, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of ViewRay, Inc. ViewRay, Inc.'s securities were suspended on July 26, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of 9 Meters Biopharma, Inc. 9 Meters Biopharma, Inc.'s securities were suspended on July 26, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares of Nabriva Therapeutics plc. Nabriva Therapeutics plc's securities were suspended on August 1, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the warrants of UTA Acquisition Corporation. UTA Acquisition Corporation's warrants were suspended on August 2, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrants of AppHarvest, Inc. AppHarvest, Inc.'s warrants were suspended on August 2, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Yellow Corporation. Yellow Corporation's securities were suspended on August 16, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Proterra Inc. Proterra Inc.'s securities were suspended on August 17, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Amyris, Inc. Amyris, Inc.'s securities were suspended on August 21, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the warrants of Chain Bridge I. Chain Bridge I's warrants were suspended on August 23, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the warrants of LatAmGrowth SPAC. LatAmGrowth SPAC's warrants were suspended on August 25, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrants of SpringBig Holdings, Inc. SpringBig Holdings, Inc.'s securities were suspended on September 5, 2023, and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq's rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.


© 2023 GlobeNewswire (Europe)
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.